Bionomics Ltd Adr Stock Book Value Per Share
| BNOXDelisted Stock | USD 4.88 0.07 1.41% |
Bionomics Ltd ADR fundamentals help investors to digest information that contributes to Bionomics' financial success or failures. It also enables traders to predict the movement of Bionomics Stock. The fundamental analysis module provides a way to measure Bionomics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bionomics stock.
Bionomics |
Bionomics Ltd ADR Company Book Value Per Share Analysis
Bionomics' Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
More About Book Value Per Share | All Equity Analysis
Book Value per Share | = | Common EquityAverage Shares |
Current Bionomics Book Value Per Share | 1.32 X |
Most of Bionomics' fundamental indicators, such as Book Value Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bionomics Ltd ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
CompetitionIn accordance with the recently published financial statements, the book value per share of Bionomics Ltd ADR is about 1.32 times. This is 177.65% lower than that of the Biotechnology sector and 100.53% lower than that of the Health Care industry. The book value per share for all United States stocks is 99.93% higher than that of the company.
Bionomics Book Value Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bionomics' direct or indirect competition against its Book Value Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bionomics could also be used in its relative valuation, which is a method of valuing Bionomics by comparing valuation metrics of similar companies.Bionomics is currently under evaluation in book value per share category among its peers.
Bionomics Fundamentals
| Return On Equity | -0.78 | |||
| Return On Asset | -0.4 | |||
| Operating Margin | 89.10 % | |||
| Current Valuation | 14.16 B | |||
| Shares Outstanding | 1.63 M | |||
| Shares Owned By Insiders | 33.91 % | |||
| Shares Owned By Institutions | 16.22 % | |||
| Number Of Shares Shorted | 400.4 K | |||
| Price To Book | 829.81 X | |||
| Price To Sales | 386.72 X | |||
| Revenue | 20 K | |||
| Gross Profit | (18.96 M) | |||
| EBITDA | (9.84 M) | |||
| Net Income | (15.49 M) | |||
| Cash And Equivalents | 33.56 M | |||
| Cash Per Share | 4.46 X | |||
| Total Debt | 272.74 K | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 12.46 X | |||
| Book Value Per Share | 1.32 X | |||
| Cash Flow From Operations | (14.68 M) | |||
| Short Ratio | 0.13 X | |||
| Earnings Per Share | (14.32) X | |||
| Target Price | 9.58 | |||
| Beta | -0.069 | |||
| Market Capitalization | 4.95 M | |||
| Total Asset | 27.65 M | |||
| Retained Earnings | (177.98 M) | |||
| Working Capital | 9.36 M | |||
| Net Asset | 27.65 M |
About Bionomics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bionomics Ltd ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bionomics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bionomics Ltd ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Consideration for investing in Bionomics Stock
If you are still planning to invest in Bionomics ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bionomics' history and understand the potential risks before investing.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |